UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AB0752 PSORIATIC ARTHRITIS: OLIGOARTHRITIS AND POLYARTHRITIS PATTERN CHANGES OVER THE INITIAL YEAR OF THE PRESENTATION. A REAL-WORLD EVIDENCE REPORT FROM THE QUEBEC REGISTRY RHUMADATA

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1672-1673

2020

Volltextzugriff (PDF)

POS0448 DISCONTINUATION RATE OF TOFACITINIB AS MONOTHERAPY IS SIMILAR COMPARED TO COMBINATION THERAPY WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.454-454

2021

Volltextzugriff (PDF)

Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry

Pain research & management, 2017-01, Vol.2017, p.8123812-16

2017

Volltextzugriff (PDF)

THU0142 Prediction of Non-Adherence in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.245-245

2015

Volltextzugriff (PDF)

THU0137 Denosumab, with and without Biologic Therapy and the Risk of Infection in Patients with Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.243-244

2015

Volltextzugriff (PDF)

Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics

Value in health, 2015-05, Vol.18 (3), p.A163-A163

2015

Volltextzugriff (PDF)

THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.190-190

2016

Volltextzugriff (PDF)

THU0035 Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from The Provincial Electronic Database and Registry Rhumadata

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.190-190

2016

Volltextzugriff (PDF)

FRI0120 The Incidence of Herpes Zoster (HZ) in A Population of Patients with Inflammatory Arthritis: A 12-Year Analysis from The Rhumadata Clinical Database and Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.471-472

2016

Volltextzugriff (PDF)

SAT0335 Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the Rhumadata® Registry: 8-Year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.713-713

2014

Volltextzugriff (PDF)

POS0325 RHEUMATOID ARTHRITIS PATIENTS AND WEATHER PATTERNS: A RHUMADATA™ STUDY OF 14,200 PATIENT-REPORTED OUTCOMES MATCHED WITH METEOROLOGICAL DATA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.408-408

2023

Volltextzugriff (PDF)

THU0262 Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.273-274

2014

Volltextzugriff (PDF)

AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.881-881

2014

Volltextzugriff (PDF)

FRI0225 Use of abatacept in patients with rheumatoid arthritis from the rhumadata® database: experience as first or second line agent compared with adalimumab and etanercept

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A449-A449

2013

Volltextzugriff (PDF)

AB0196 IMPACT OF ANTIRHEUMATIC TREATMENTS ON THE INDIVIDUAL COMPONENTS OF THE ACR COMPOSITE SCORE IN PATIENTS WITH RA: REAL-WORLD DATA FROM TWO REGISTRIES

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1280-1280

2023

Volltextzugriff (PDF)

OP0179 DISCONTINUATION RATE OF TOFACITINIB IS SIMILAR WHEN COMPARED TO TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.107-108

2021

Volltextzugriff (PDF)

SAT0423 Increased prevalence of extra-articular manifestations among individuals with ankylosing spondylitis in canada: results from the rhumadata® multicentre registry

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.931

2017

Volltextzugriff (PDF)

POS0057 WHICH ADVANCED TREATMENT SHOULD BE USED FOLLOWING THE FAILURE OF A FIRST-LINE ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS? 15 YEARS OF EVIDENCE FROM THE QUEBEC REGISTRY RHUMADATA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.239-239

2023

Volltextzugriff (PDF)

AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1467-1467

2020

Volltextzugriff (PDF)

FRI0331 COMPARISON OF THE THERAPEUTIC TRAJECTORIES OF PATIENTS WITH OLIGO AND POLYARTICULAR PSORIATIC ARTHRITIS. A REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.757-758

2020

Volltextzugriff (PDF)

THU0179 PERSISTENCE IN RHEUMATOID ARTHRITIS PATIENTS ON BIOSIMILAR AND BIO-ORIGINATOR ETANERCEPT: A POOLED ANALYSIS OF PAN-CANADIAN COHORTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.306-307

2020

Volltextzugriff (PDF)

MODELING THE COST-EFFECTIVENESS OF RITUXIMAB USE COMPARED TO TUMOR NECROSIS FACTOR INHIBITORS (ANTI-TNF) AGENTS AS A SECOND-LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN QUEBEC, CANADA USING RHUMADATA REGISTRY DATA

Value in health, 2017-05, Vol.20 (5), p.A147

2017

Volltextzugriff (PDF)

PMS60 - Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics

Value in health, 2015-05, Vol.18 (3), p.A163-A163

2015

Volltextzugriff (PDF)

SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.845

2017

Volltextzugriff (PDF)

AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.1188

2017

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Life Sciences & Biomedicine
(61)
Humans
(58)
Male
(44)
Middle Aged
(37)
Female
(36)
Adult
(34)
Aged
(34)
Physics
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Physical Sciences
(24)
General & Internal Medicine
(20)
Elementary Particles
(19)
Medicine, General & Internal
(19)
Physics Of Elementary Particles And Fields
(19)
Bosons
(16)
Risk Factors
(15)
Interactions
(14)
Particle Interactions
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

AB0752 PSORIATIC ARTHRITIS: OLIGOARTHRITIS AND POLYARTHRITIS PATTERN CHANGES OVER THE INITIAL YEAR OF THE PRESENTATION. A REAL-WORLD EVIDENCE REPORT FROM THE QUEBEC REGISTRY RHUMADATA

POS0448 DISCONTINUATION RATE OF TOFACITINIB AS MONOTHERAPY IS SIMILAR COMPARED TO COMBINATION THERAPY WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA

Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry

THU0142 Prediction of Non-Adherence in Patients with Rheumatoid Arthritis

THU0137 Denosumab, with and without Biologic Therapy and the Risk of Infection in Patients with Rheumatoid Arthritis

Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics

THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry

THU0035 Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from The Provincial Electronic Database and Registry Rhumadata

FRI0120 The Incidence of Herpes Zoster (HZ) in A Population of Patients with Inflammatory Arthritis: A 12-Year Analysis from The Rhumadata Clinical Database and Registry

SAT0335 Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the Rhumadata® Registry: 8-Year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab

POS0325 RHEUMATOID ARTHRITIS PATIENTS AND WEATHER PATTERNS: A RHUMADATA™ STUDY OF 14,200 PATIENT-REPORTED OUTCOMES MATCHED WITH METEOROLOGICAL DATA

THU0262 Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry

AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

FRI0225 Use of abatacept in patients with rheumatoid arthritis from the rhumadata® database: experience as first or second line agent compared with adalimumab and etanercept

AB0196 IMPACT OF ANTIRHEUMATIC TREATMENTS ON THE INDIVIDUAL COMPONENTS OF THE ACR COMPOSITE SCORE IN PATIENTS WITH RA: REAL-WORLD DATA FROM TWO REGISTRIES

OP0179 DISCONTINUATION RATE OF TOFACITINIB IS SIMILAR WHEN COMPARED TO TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS: POOLED DATA FROM TWO RHEUMATOID ARTHRITIS REGISTRIES IN CANADA

SAT0423 Increased prevalence of extra-articular manifestations among individuals with ankylosing spondylitis in canada: results from the rhumadata® multicentre registry

POS0057 WHICH ADVANCED TREATMENT SHOULD BE USED FOLLOWING THE FAILURE OF A FIRST-LINE ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS? 15 YEARS OF EVIDENCE FROM THE QUEBEC REGISTRY RHUMADATA

AB0337 TOFACITINIB MONOTHERAPY OR COMBINED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS SHOW SIMILAR RETENTION OVER FOUR YEARS. REPORT FROM RHUMADATA

FRI0331 COMPARISON OF THE THERAPEUTIC TRAJECTORIES OF PATIENTS WITH OLIGO AND POLYARTICULAR PSORIATIC ARTHRITIS. A REPORT FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY

THU0179 PERSISTENCE IN RHEUMATOID ARTHRITIS PATIENTS ON BIOSIMILAR AND BIO-ORIGINATOR ETANERCEPT: A POOLED ANALYSIS OF PAN-CANADIAN COHORTS

MODELING THE COST-EFFECTIVENESS OF RITUXIMAB USE COMPARED TO TUMOR NECROSIS FACTOR INHIBITORS (ANTI-TNF) AGENTS AS A SECOND-LINE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN QUEBEC, CANADA USING RHUMADATA REGISTRY DATA

PMS60 - Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics

SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry

AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry

Suchergebnisse filtern